MRIGlobal Wins $54-Million Contract to Support Drug Development
MRIGlobal recently announced it has been awarded a $54-million, 10-year program from the National Institute of Neurological Disorders and Stroke to provide support for the development and manufacturing of drug candidates for ultimate use in human clinical trials.
The project entails process development and preparation APIs; preformulation and formulation studies; analytical method development and validation; stability studies; drug product manufacturing, packaging, labeling; and storage and distribution of the drug products for clinical trials.
“Neurological disorders and stroke impact hundreds of millions of people worldwide,” said Thomas M. Sack, PhD, President and Chief Executive Officer of MRIGlobal. “We are honored to support NIH in securing drugs that could literally transform the lives of so many impacted by stroke and a multitude of neurological diseases, such as Alzheimer Disease, autism, Parkinson’s Disease, epilepsy, muscular dystrophy, muscular sclerosis, and migraines.”
“This is a very exciting opportunity,” said Roger K. Harris, PhD, Associate Vice President, Global Health Security. “While MRIGlobal has worked with the NIH since 1969, this is our first program with the National Institute of Neurological Disorders and Stroke and it opens a new era of collaboration working closely with organizations like University of Kansas, University of Kansas Medical Center, and Kansas City University of Medicine and Biosciences to help bring new treatment and hope to those afflicted with neurological disorders and stroke.”
This project is funded in whole or in part with Federal funds from the National Institute of Neurological Disorders and Stroke, National Institutes of Health, Department of Health and Human Services, under Contract No. HHSN271201500006i.
MRIGlobal, an independent research and development organization, delivers solutions in global health, national security and defense, and energy and the environment. The organization performs scientific research, advanced engineering, and program integration and management for clients in industry, government, and academia. Established in 1944 as Midwest Research Institute, MRIGlobal is based in Kansas City, MO, and operates in nine states and Washington, DC. MRIGlobal employs more than 500 and manages 2,600-plus workers through management and operations programs with various clients.
MRIGlobal is one of two partners in the Alliance for Sustainable Energy LLC, which manages and operates the National Renewable Energy Laboratory (NREL) in Golden, CO, for the US Department of Energy. For more information, visit www.mriglobal.org.
Total Page Views: 1042
